HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis.

AbstractBACKGROUND:
Prior studies of α-linolenic acid (ALA), a plant-derived omega-3 (n-3) fatty acid, and cardiovascular disease (CVD) risk have generated inconsistent results.
OBJECTIVE:
We conducted a meta-analysis to summarize the evidence regarding the relation of ALA and CVD risk.
DESIGN:
We searched multiple electronic databases through January 2012 for studies that reported the association between ALA (assessed as dietary intake or as a biomarker in blood or adipose tissue) and CVD risk in prospective and retrospective studies. We pooled the multivariate-adjusted RRs comparing the top with the bottom tertile of ALA using random-effects meta-analysis, which allowed for between-study heterogeneity.
RESULTS:
Twenty-seven original studies were identified, including 251,049 individuals and 15,327 CVD events. The overall pooled RR was 0.86 (95% CI: 0.77, 0.97; I² = 71.3%). The association was significant in 13 comparisons that used dietary ALA as the exposure (pooled RR: 0.90; 95% CI: 0.81, 0.99; I² = 49.0%), with similar but nonsignificant trends in 17 comparisons in which ALA biomarkers were used as the exposure (pooled RR: 0.80; 95% CI: 0.63, 1.03; I² = 79.8%). An evaluation of mean participant age, study design (prospective compared with retrospective), exposure assessment (self-reported diet compared with biomarker), and outcome [fatal coronary heart disease (CHD), nonfatal CHD, total CHD, or stroke] showed that none were statistically significant sources of heterogeneity.
CONCLUSIONS:
In observational studies, higher ALA exposure is associated with a moderately lower risk of CVD. The results were generally consistent for dietary and biomarker studies but were not statistically significant for biomarker studies. However, the high unexplained heterogeneity highlights the need for additional well-designed observational studies and large randomized clinical trials to evaluate the effects of ALA on CVD.
AuthorsAn Pan, Mu Chen, Rajiv Chowdhury, Jason H Y Wu, Qi Sun, Hannia Campos, Dariush Mozaffarian, Frank B Hu
JournalThe American journal of clinical nutrition (Am J Clin Nutr) Vol. 96 Issue 6 Pg. 1262-73 (Dec 2012) ISSN: 1938-3207 [Electronic] United States
PMID23076616 (Publication Type: Journal Article, Meta-Analysis, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review, Systematic Review)
Chemical References
  • Biomarkers
  • alpha-Linolenic Acid
Topics
  • Biomarkers (blood)
  • Cardiovascular Diseases (blood, epidemiology, etiology, prevention & control)
  • Diet (adverse effects)
  • Humans
  • Reproducibility of Results
  • Risk
  • alpha-Linolenic Acid (administration & dosage, blood, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: